Israeli remote care automation company, Datos Health has announced a collaboration with AI-based clinical insights provider, Medial EarlySign to offer an integrated platform that identifies high-risk patients who would benefit from remote care programmes.

WHY IT MATTERS

Combining both companies' core technologies, the partnership aims to help providers achieve better outcomes in vulnerable populations, as they transition to value-based care.

The collaboration combines EarlySign’s predictive solutions for identifying patients at increased risk of chronic or life-threatening conditions with Datos’s corresponding automated remote care programmes, helping to prevent or delay the onset of disease and downstream complications.

The introduction of this solution is significant during the pandemic as high-risk population management becomes crucial for healthcare providers and the delivery of preventative services increases in demand.  

THE LARGER CONTEXT

Last year, Datos partnered with Vaica Medical to include medication adherence information as part of Datos's offering of patient data. The solution was implemented at Israel's Sheba Medical Center.

At the beginning of the pandemic, Datos's remote patient monitoring platform, Tyto Care's connected devices, and a robot from InTouch Health helped Sheba Hospital treat and monitor patients in quarantine and at home.

ON THE RECORD

Ori Geva, CEO and co-founder of Medial EarlySign said: “The transition to value-based care and pre-emptive approaches requires deeper insight into the patient population. Medial EarlySign’s AI-based clinical approach facilitates proactive and preventative treatment through earlier identification of high-risk patient trajectories when interventions stand more chance of halting or preventing the onset of disease.

“Datos provides healthcare stakeholders new options and models of intervention for these high-risk patients, including a way to seamlessly enable more frequent, or even continuous monitoring and engagement that can reduce intervention costs and significantly improve care delivery and patient outcomes."

Uri Bettesh, CEO and founder of Datos Health said: “Datos has spent the last several years focused on building a solution for personalised and automated remote care across a diverse range of disease conditions, enabling better care and a higher level of patient engagement and participation.

“The prospect of extending automated remote care to pre-disease and early onset stages opens up a new world of possibilities for the ultimate goal of keeping people healthier for longer.”